Bluejay diagnostics reports first quarter 2023 financial results

Acton, mass., may 10, 2023 (globe newswire) -- bluejay diagnostics, inc. (nasdaq: bjdx) (“bluejay” or the “company”), a medical diagnostics company developing rapid tests using whole blood on its symphony platform to improve patient outcomes in critical care settings, today announced financial results for the quarter ended march 31, 2023.
BJDX Ratings Summary
BJDX Quant Ranking